E S Venkatraman

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi A permutation test to compare receiver operating characteristic curves
    E S Venkatraman
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Biometrics 56:1134-8. 2000
  2. ncbi Properties of a nonparametric test for early comparison of treatments in clinical trials in the presence of surrogate endpoints
    E S Venkatraman
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Biometrics 55:1171-6. 1999
  3. ncbi Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response
    M W Skwarchuk
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Int J Radiat Oncol Biol Phys 47:103-13. 2000
  4. ncbi Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
    S Levegrun
    Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1245-60. 2000
  5. ncbi Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data
    S Levegrun
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 51:1064-80. 2001
  6. ncbi Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms
    A Jackson
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:685-98. 2001
  7. ncbi Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:601-8. 2000
  8. ncbi Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically
    V W Rusch
    Department of Surgery, and Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 68:1799-804. 1999
  9. ncbi Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 23:826-31. 2005
  10. ncbi Identification of prognostic factors in advanced epithelial ovarian carcinoma
    D S Chi
    Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Gynecol Oncol 82:532-7. 2001

Detail Information

Publications20

  1. ncbi A permutation test to compare receiver operating characteristic curves
    E S Venkatraman
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Biometrics 56:1134-8. 2000
    ..Here we extend the underlying concepts to develop a permutation test for continuous unpaired data, and we study its properties through simulations...
  2. ncbi Properties of a nonparametric test for early comparison of treatments in clinical trials in the presence of surrogate endpoints
    E S Venkatraman
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Biometrics 55:1171-6. 1999
    ..Our research indicates that, in the absence of modeling assumptions, auxiliary information derived from surrogate endpoints can provide significant additional information only under special circumstances...
  3. ncbi Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response
    M W Skwarchuk
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Int J Radiat Oncol Biol Phys 47:103-13. 2000
    ....
  4. ncbi Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
    S Levegrun
    Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1245-60. 2000
    ..To investigate tumor control following three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer and to identify dose-distribution variables that correlate with local control assessed through posttreatment prostate biopsies...
  5. ncbi Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data
    S Levegrun
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 51:1064-80. 2001
    ..We discuss differences in the radiobiologic parameters and dose-response curves and demonstrate pitfalls in interpreting the results...
  6. ncbi Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms
    A Jackson
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:685-98. 2001
    ..The purpose of this study is to identify features of the cumulative dose-volume histogram (DVH) for the rectal wall that correlate with late rectal bleeding after 3D-CRT for prostate cancer...
  7. ncbi Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:601-8. 2000
    ..To compare the target coverage and dose to normal tissues after I-125 transperineal permanent implantation (TPI) of the prostate in 90 patients treated with one of three different transperineal techniques...
  8. ncbi Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically
    V W Rusch
    Department of Surgery, and Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 68:1799-804. 1999
    ..The factors influencing outcome after resection of malignant pleural mesothelioma (MPM) are controversial. This analysis of a prospective surgical database identifies important prognostic factors...
  9. ncbi Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 23:826-31. 2005
    ..To identify predictors of distant metastases (DM) among patients who develop an isolated prostate-specific antigen (PSA) relapse after definitive external-beam radiotherapy for clinically localized prostate cancer...
  10. ncbi Identification of prognostic factors in advanced epithelial ovarian carcinoma
    D S Chi
    Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Gynecol Oncol 82:532-7. 2001
    ....
  11. ncbi High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 166:876-81. 2001
    ..Intensity modulated radiation therapy is associated with minimal rectal and bladder toxicity, and, hence, represents the treatment delivery approach with the most favorable risk-to-benefit ratio...
  12. ncbi Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size
    Katherine S Panageas
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Stat Med 26:2017-35. 2007
    ..By contrast, the cluster weighted GEE method is inefficient...
  13. ncbi Two-stage designs for gene-disease association studies with sample size constraints
    Jaya M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Biometrics 60:589-97. 2004
    ....
  14. ncbi Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy
    J Martin
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 72:1149-54. 2001
    ..However, right pneumonectomy is associated with a significantly increased risk and should be performed only in selected patients...
  15. ncbi Optimal two-stage design for a series of pilot trials of new agents
    T J Yao
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Biometrics 54:1183-9. 1998
    ..The reliability of the results is evaluated using the bootstrap...
  16. ncbi High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 53:1111-6. 2002
    ..To report the acute and late toxicity and preliminary biochemical outcomes in 772 patients with clinically localized prostate cancer treated with high-dose intensity-modulated radiotherapy (IMRT)...
  17. ncbi The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
    D S Chi
    Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 77:227-31. 2000
    ..These patients may be candidates for initial laparoscopic evaluation to obtain a confirmatory tissue diagnosis and to determine resectability...
  18. ncbi Two-stage designs for gene-disease association studies
    Jaya M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Biometrics 58:163-70. 2002
    ..This translates to screening all the markers on approximately one quarter of the required sample size in stage 1...
  19. ncbi Circular binary segmentation for the analysis of array-based DNA copy number data
    Adam B Olshen
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Biostatistics 5:557-72. 2004
    ..The method is evaluated by simulation and is demonstrated on cell line data with known copy number alterations and on a breast cancer cell line data set...
  20. ncbi A faster circular binary segmentation algorithm for the analysis of array CGH data
    E S Venkatraman
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Bioinformatics 23:657-63. 2007
    ..This makes the full permutation approach computationally prohibitive for the newer arrays that contain tens of thousands markers and highlights the need for a faster algorithm...